PLATINUM AND GOLD SPONSORS
SPONSORS
SPONSORS
SUPPORTED BY
Dr. Petrina Kamya is a computational chemist specializing in computer-aided molecular design with a career spanning academic research and industry leadership roles. She earned her Ph.D. in theoretical chemistry from Concordia University, where she researched RNA structure interactions and small molecule design. Transitioning to industry, Dr. Kamya joined Chemical Computing Group (CCG) in Montreal where she played a pivotal role in sales and business development, focusing on molecular modeling software tailored for pharmaceutical and biotech companies and academic institutions. At Certara, she consulted for pharmaceutical companies, offering strategic insights on market access and drug commercialization.
At Insilico Medicine, she oversees the corporate strategy for the AI-driven platforms and services. Her expertise bridges computational chemistry and AI, driving innovation in molecular discovery.
Bethan Howells is a Senior Automation Scientist within AstraZeneca’s High Throughput Screening (HTS) Department. Her primary responsibility entails the design and optimization of automated screening protocols for biochemical, biophysical, and cell-based high-throughput screens. Bethan is also involved in the identification and implementation of innovative automation workflows to drive operational efficiency and advancement. Notably, over the past year, Bethan has played a pivotal role in the successful relocation and installation of AstraZeneca’s HTS automation platforms from Alderley Park, Cheshire to The Discovery Centre, Cambridge. Prior to this role, Bethan has 6.5 years’ experience within AstraZeneca, in HTS Screening and DNA-Encoded Library Screening.
Joel Poissonnier leads the Manufacturing Intelligence team, as part of the Data, Digital and Technology (DD&T) group in Takeda. He is also the business partner of a group called Global Manufacturing Science, composed mainly of Process Scientists supporting all Takeda production sites. Prior to this, he spent 20 years in the Engineering & Automation domains with Baxter, 12 years in MES global deployments with Baxter/Baxalta/Shire and 3 years in IT/OT Cybersecurity & Solution Architecture with Takeda. His background is Industrial Engineering in Electro-Mechanics and Master in Biomedical Engineering.
Rob Brown is Global VP, Head of Scientific Office Sapio Sciences. Prior to joining Sapio Sciences, he spent eight years at Dotmatics where he held various positions including Head of Global Presales and Head of Product Marketing & Product Management. Earlier in his career he was responsible for product marketing teams for cheminformatics and bioinformatics at Accelrys, SciTegic and MSI. Rob started his career as a postdoc and later research scientist in the Computer Aided Molecular Design department at Abbott Laboratories (now Abbvie). He received his PhD in Cheminformatics from the University of Sheffield, UK.
Live Lab sessions are interactive group discussions which tackle the bigger questions of the day in an open forum to brainstorm ideas and discuss the roadblocks to break-through innovation. They take the format of moderated standing discussions. The objective is to share views and experiences to stimulate new ways of thinking about common objectives.
Jesper Lau (JL) started with Novo Nordisk as bench chemists in 1990 working with small molecules but was quickly promoted to project manager for a specific project aiming to discover small molecule GLP-1 agonists as well as glugacon receptor antagonists. From 2003 JL was leading a new organization composed of organic chemists with experience from tradition medicinal chemistry that were transitioning into the untouched field of peptide and protein engineering aiming to build new capabilities on how to turn unstable peptides and proteins into effective and safe pharmaceuticals with long duration of action. Semaglutide was invented as the first once weekly GLP-1 based on human GLP-1 which has today inspired many others to follow.
How digital, done right, can foster a data culture, while establishing a data foundation for the future.
Kåre is a product owner at Novo Nordisk. He holds a master’s degree in IT, organization, and economics from Copenhagen Business School. With over 20 years of experience in digital transformation across R&D and various sectors.
For the past many years, Kåre has been driven by finding a solution to the fundamental dilemma of digital transformation in research; Research challenges the known, while IT products focus on optimizing and scaling the known. The tangible outcome of the product sciworm, short for scientific workflow management.
Joe is a Senior Data & AI Executive at Cancer Research Horizons, leading its Data & AI team to facilitate access to high-quality cancer research data for academic and commercial use. With extensive experience in research Data Partnerships, he has led data-focused initiatives at Cancer Research Horizons for six years, following various roles at Cancer Research Horizons and Cancer Research UK. Before transitioning to Business Development, he trained as a biochemist at the University of Oxford.
